Next Article in Journal
The Nephroprotective Effect of Nitric Oxide during Extracorporeal Circulation: An Experimental Study
Previous Article in Journal
Imiquimod Reverses Chronic Toxoplasmosis-Associated Behavioral and Neurocognitive Anomalies in a Rat Model
Previous Article in Special Issue
Ferritin and Ferritin-to-Hemoglobin Ratio as Promising Prognostic Biomarkers of Severity in Acute Pancreatitis—A Cohort Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Alcoholic Acute Pancreatitis, a Retrospective Study about Clinical Risk Factors and Outcomes—A Seven-Year Experience of a Large Tertiary Center

by
Deniz Gűnșahin
1,2,
Andrei Vicențiu Edu
1,3,*,
Mihai Radu Pahomeanu
1,3,
Tudor Ștefan Mitu
1,
Andreea Irina Ghiță
1,
Anamaria Simona Odorog
1,
Carmen Monica Preda
1,4 and
Lucian Negreanu
1,3
1
Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, B-dul. Eroii Sanitari, 8, 050474 Bucharest, Romania
2
Gastroenterology Department, Emergency Clinical Hospital Bucharest, Calea Floreasca, 8, 014461 Bucharest, Romania
3
Internal Medicine & Gastroenterology Department, University Emergency Hospital of Bucharest, Splaiul Independenței, 169, 050098 Bucharest, Romania
4
Gastroenterology Department, Fundeni Clinical Insititute, Soseaua Fundeni, 258, 022328 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Biomedicines 2024, 12(6), 1299; https://doi.org/10.3390/biomedicines12061299
Submission received: 24 April 2024 / Revised: 8 June 2024 / Accepted: 10 June 2024 / Published: 12 June 2024
(This article belongs to the Special Issue Pancreatitis: Etiology, Pathology, and Treatment)

Abstract

:
(1) Background: Alcohol consumption is one of the main causes of acute pancreatitis. (2) Material and Methods: In this unicentric retrospective cohort study, we selected 1855 patients from the Bucharest Acute Pancreatitis Index (BUC-API) who presented with acute pancreatitis. We investigated correlations between Alcoholic Acute Pancreatitis (AAP) and the rate of complications, cost, length of hospitalization and rate of recurrence. (3) Results: We found a moderately strong association between AAP and recurrence (p < 0.01) and observed that the disease is likelier to evolve with pseudocysts and walled-off necrosis than other forms of AP. Patients with AAP are less likely to have a morphologically normal pancreas than patients suffering from AP of other causes (p < 0.01), but a low probability of requiring intensive care unit admission (p < 0.01) significantly lowers daily cost (Md = 154.7 EUR compared to Md = 204.4 EUR) (p < 0.01). (4) Conclusions: This study’s data show that patients with AAP have a greater rate of pseudocyst occurrence, lower intensive care unit admittance rate and lower cost of hospitalization than patients with AP of other causes. Typical Sketch: A middle-aged male tobacco smoker with recurrent AP, lower risk of in-hospital mortality and complications such as pseudocysts; treated in a gastroenterological ward and discharged at-will.

1. Introduction

With a prevalence rate ranging from 8.8% in Israel [1] to 47% in Finland [2], alcohol consumption, defined by the Center for Disease Control (CDC) [3] as consuming more than 40 g of pure alcohol per day, is one of the main etiologies of AP worldwide.
In-hospital mortality in AAP depends on the type of study selected, but varies between 1.1% [4] and 8.4% [5]. The highest mortality rate related to AAP has been reported in Russia (2.7/100,000 people) [6].
In the current study, we sought to address a gap in AAP research related to prevention strategies by improving medical knowledge related to modifiable risk factors and effective prevention strategies. We aimed to evaluate the associations between AAP and several clinical and demographic attributes related to known causes of AP. Our main aim was to investigate the possible significant links with ICU admittance. A secondary aim was to establish links between the following variables and AAP: age, sex, outcome at discharge, ward of origin, morphology, rurality, tobacco smoking, daily cost of hospitalization, severity and length of stay (LoS). These factors are useful not only in determining those at risk of developing AAP in the general population but also in finding primary prophylaxis measures and optimizing healthcare systems that treat this illness.

2. Materials and Methods

2.1. Bucharest Acute Pancreatitis Index (BUC-API)

This large retrospective cohort study included patients selected from the BUC-API registry, a unicentric registry of 2039 cases of AP, recurrent AP and acute-on-chronic pancreatitis.
Using the BUC-API registry was approved by the IRB at the University Emergency Hospital of Bucharest (Spitalul Universitar de Urgență București). Informed consent on behalf of the patients was obtained before hospitalization. This study follows the STROBE guidelines and the ethical guidelines of the 1975 Declaration of Helsinki.
Although the cases analyzed in this study represent 35 of the 42 counties in Romania, most of the registry’s cases were treated in southern Romania in Bucharest and in Giurgiu, Ilfov and Teleorman counties.
Cases from 1 June 2015 to 1 April 2022 were selected from the electronic health records (EHRs) at the University Emergency Hospital of Bucharest using the ICD-10 codes K85, B26.3 and B25.2 as consecutive hospitalizations.
Initially, we found 2520 cases, which were then screened by trained medical staff. Of these, we excluded 52 miscoded cases and 426 duplicates caused by software processing errors. An additional 184 cases were found to be acute-on-chronic pancreatitis cases that had not been excluded previously because of a lack of ICD-10 codes regarding this condition, which is differentiated from AP and RAP by the following: known previous diagnosis of chronic pancreatitis, concerning imaging findings (calcifications in pancreatic parenchyma, pancreatic duct dilation and/or proofs of exocrine pancreatic insufficiency). The co-existence of a tumoral mass within the pancreas (primary carcinoma or secondary determination) represented an exclusion criterion from the registry. In total, 1855 consecutive cases of AP in 1618 unique patients were included in the current study. To the best of our knowledge, this is the largest registry study of pancreatitis performed to date in our country.
Founded in 1978, the University Emergency Hospital of Bucharest is the largest acute-care tertiary teaching hospital in Romania. It accommodates 1099 beds and has both gastroenterological and abdominal surgery departments.

2.2. Case Selection and Definitions

Details regarding the patients’ characteristics relevant to this study are found in Table 1. In order to control for statistical bias, for any patient that had multiple episodes in our registry, we took into consideration only the last chronological episode.
Patients that had no data regarding daily cost, morphology, residency or tobacco usage were excluded from the statistical analysis of that particular subject.
Severity and morphology were stratified as in the Revised Atlanta Classification [7].
Tobacco smoking was considered former if it had ceased at least 4 weeks before hospital admission; however, quantifying how many packs of cigarettes were smoked by all active and former smokers was impossible to determine from the data available in EHRs.
Etiology was stratified as in “Sleisenger and Fordtran’s Gastrointestinal and Liver Diseases”, 10th edition [8].
To determine the alcoholic cause of AP, we applied the IAP/APA guidelines [9] regarding interviews of patients with AAP (to assess heavy drinking). Interview was conducted by the caring physician. Where doubt was retained relating to the alcoholic etiology after interview the caring physician sought additional indirect proofs like (a majority of them should have been positive simultaneously): deRitis ratio >2.0, macrocytosis absent, B12 deficiency or other hematological disease that could explain it, gamma-glutamyl transferase high in absence of any hepatic disease that could explain it, paper-money skin sign, essential tremor unexplained by other neurological or psychiatric pathology, Dupuytren contracture and alcohol withdrawal signs after 24 h from admission.
To make better comparisons with the AAP group, all cases of AP not of alcoholic were combined to form the other-cause AP (OAP) group.
Patients suffering from acute-on-chronic pancreatitis (calcification in pancreas, dilation of pancreatic ducts and/or proofs of exocrine pancreatic insufficiency) were excluded from the study population before any analysis.
A patient’s first attack of AP during the selected registry timeframe was considered any case that did not mention previous hospitalization in our hospital or prior episodes of AP.
The outcome of each case was documented as reported by the case physician. The cost of hospitalization was calculated in RON and reported in EUR by conversion with the exchange rate published by Romanian National Bank on 10 May 2024, respectively 1.00 EUR = 4.97 RON.

2.3. Statistical Analysis

The database used in this study was organized using Excel 2019 and Google Docs. To analyze the cohort’s general characteristics (Table 1), frequency tests were used. Pearson’s chi-square test and Cramer’s V (phi test) were used to evaluate the correlations between two categorical variables. The Mann–Whitney U test was used to assess correlations between continuous and other categorical variables. All statistical tests were performed using IBM SPSS ver. 29.0.0.0. Statistical significance was achieved at p < 0.05. A third decimal place was reported only when the p-value was between 0.04 and 0.05.

3. Results

3.1. Population Characteristics

We found 1618 consecutive patients with AP in our registry. Of the patients in our registry, over half were male (n = 918, 56.7%). The patients’ median age was 59.0 years (IQR = 26.0). Relatively equal numbers of admittances to the gastroenterology and surgery wards, which lasted a median LoS of 7.0 days (IQR = 6.0), were noted.
We established a median daily cost of 177.2 EUR. At discharge, the majority of patients (n = 1329, 82.1%) achieved a good outcome (healed or ameliorated). Most (n = 821, 50.7%) experienced a mild course of disease, with few cases necessitating ICU admittance (n = 169, 10.4%). Concerning morphology, as per the Revised Atlanta Classification, we discovered that 38.7% (n = 626) developed interstitial pancreatitis.
Of the patients, 503 (31.1%) were classified as having AAP. Of the remaining patients, we found a rate of idiopathic AP at 15.6% (n = 253).
Most of our subjects lived in urban areas (n = 1159, 71.6%). Some cases (n = 355, 21.9%) had data regarding tobacco smoking status; most of those reported active smoking (n = 250, 15.5% of total population).

3.2. Recurrence

We performed a chi-square test of independence to identify a correlation between AAP and recurrence and found a significant moderate association between the two variables: χ2 (1, n = 1618) = 107.8, p < 0.01. Thus, AAP cases are likelier to be associated with recurrence (see Table 2 and Figure 1).

3.3. Outcome at Discharge

A chi-square test of independence was performed to assess the relationship between etiology and outcome at discharge, revealing a significant relationship between the two variables: χ2 (4, n = 1618) = 34.5, p < 0.01. In addition, a phi test (φ = 0.15) revealed a moderate magnitude association. We observed that patients with AAP were likelier to be discharged at-will but less likely to be transferred and to suffer from in-hospital mortality (see Table 2).

3.4. Gender

To evaluate the affiliation of gender with AAP, we performed a chi-square test of independence, finding that men are more prone to developing AAP than women: χ2 (1, n = 1618) = 307.0, p < 0.01, φ = 0.44 (see Figure 2).

3.5. Age

A Mann–Whitney U test was conducted to determine whether associations between age and AAP existed. The results revealed that AAP develops at a significantly younger age (M = 52.0 years, SD = 13.0) than other forms of AP (M = 60.3 years, SD = 18.1) (U = 365,910.5, p < 0.01) (see Figure 3).

3.6. Severity

To determine an association between etiology and severity, we ran a chi-square test of independence, finding no significant differences between the two groups: χ2 (2, n = 1618) = 2.5, p = 0.28.

3.7. ICU Admittance

To determine a correlation between etiology and ICU necessitation, we conducted a chi-square test of independence, which showed a lower probability of patients’ with AAP requiring ICU admittance, although the association was weak: χ2 (1, n = 1618) = 17.1, p < 0.01, φ = 0.1 (see Figure 4).

3.8. Morphology

A chi-square test of independence was carried out to determine if there were any associations between etiology and morphology. The results showed medium magnitude statistically significant associations: χ2 (5, n = 1114) = 29.6, p < 0.01, φ = 0.16. Thus, AAP is likelier to evolve with pseudocysts and WON, and patients are less likely to have a morphologically normal pancreas (see Figure 5).

3.9. Cost of Hospitalization

To assess if there were any cost discrepancies regarding treating AAP, we performed a Mann–Whitney U test, which revealed a significantly lower daily expense for patients with AAP (M = 311.1 EUR, SD = 2878.9) than patients with OAP (M = 552.4 EUR, SD = 4029.1) (U = 280,087.0, p < 0.01).

3.10. Type of Caring Ward

To determine whether patients with AAP were admitted to a particular ward, we used a chi-square test of independence. The results showed substantial differences between the two variables and a strong magnitude association: χ2 (1, n = 1618) = 333.8, p < 0.01, φ = −0.45. In our study, patients with AAP were likelier to be admitted to the gastroenterological ward.

3.11. Urban or Rural Residency

To assess the correlation between residency and type of AP, we used a chi-square test of independence, finding no significant link: χ2 (1, n = 1604) = 1.44, p = 0.23.

3.12. Tobacco Usage

A chi-square test was performed to determine any association between patients with AAP and their use of tobacco products. A medium magnitude association strength was found: χ2 (2, n = 355) = 24.1, p < 0.01, φ = 0.26. Patients with AAP were likelier to be active tobacco smokers.

3.13. Number of Days of Stay (LoS)

To determine a correlation between LoS and etiology, we ran a Mann–Whitney U test, which revealed no significant differences (U = 280,428.5, p = 0.99).

4. Discussion

AAP remains the most common etiology of AP in many areas of the world, especially Eastern Europe [6] and our country [10].
In this study, we looked at whether there are any significant differences between AAP and all other etiologies of AP in terms of recurrence of acute episodes, evolution, hospitalization costs and complications.
Because of the recent increased interest regarding the risk factors of recurrent AP [11,12,13], researchers have found an association between RAP and AAP. This is of great importance because RAP frequently progresses into chronic pancreatitis, an independent risk factor for pancreatic cancer. Most probably this effect is not likely as much related to the toxicity of ethanol but to its pattern of usage as most other causes of AP, mainly biliary, find their resolution if not in the index admission soon after, alcoholism is a chronic state in which the patient exposes itself repeatedly to the risk factor and as such expose themself to other episodes of AP. This discussion should be dealt by prospective studies with long follow-up periods.
Compared with OAP the in-hospital mortality rate was statistically significant lower. Still, we documented a higher in-hospital mortality rate (4.4%) in patients with AAP than comparable studies’ rates of 1.3% [14], 2.63% [15] and 1.0% [16]; however, these studies’ outcome data originated in the USA, so a bias may be present related to differences in wealth, healthcare systems and medical access.
While we could not find studies that mentioned the rate of at-will discharge or transfer to other hospital units, we considered these variables important in cases of patients with AAP because we observed meaningful differences between the groups. We believe that at-will discharging may negatively influence outcomes but that it is possible to lower the rate by well-tailored psychological interventions.
As in previous studies [17,18], we found that men were more prone to AAP. In contrast, research [19] on an Asian population found that, at the same drinking levels, women are more at risk of developing AAP than men. However, several general studies [20,21,22] on gender differences regarding binge drinking alcohol revealed that men are likelier to have higher alcoholism rates than women. Therefore, it is possible that our findings are likelier to stem from a higher prevalence of male alcoholism and a dose-dependent exposure. Indeed, in 2015, a meta-analysis [23] indicated a beneficial effect of moderate alcohol consumption (<40 g/day) in women that was not observed in male populations.
Our results in terms of age are congruent with the literature [24,25,26,27,28]; the median age of patients with AP ranges from 50 years [27] to 58 years [25] depending on the studied population and/or methodology. Notably, all relevant research comparing AAP with AP of other etiological causes (mainly biliary) has found that patients with AAP are either significantly younger [26,27,29] or that alcoholism is the main cause of AP in younger populations [24,28].
A prevalence of ICU admittance was found in our population of patients, similar to the findings of a large retrospective cohort study [27]. We discovered that patients with AAP are less likely to be admitted to the ICU, a finding similar to the results of Pu et al. [30], who compared AAP with biliary and hypertriglyceridemic AP, and Goyal et al. [15], who compared AAP with hypertriglyceridemic AP alone. Other researchers, such as Garcia et al. [31] and Balint et al. [32], found no differences pertinent to ICU admittance and AP etiology. However, a study from 2016 [33] revealed a higher rate of ICU admission in patients with AAP than in patients with OAP. All the divergent results might provide a glimpse into the heterogeneity of ICU rules of admission in terms of patients with AP; thus, we encourage their standardization. We did not see any statistically meaningful differences regarding LoS in the ICU.
We did not see any important differences concerning severity, as defined by the Revised Atlanta Classification [7]. Other investigators [2] found cases of AAP with milder severities. In a large retrospective cohort investigation conducted on an Asian population in 2017 [18], there were no differences among patients with AAP in terms of severity in the all-age population, although they found a higher incidence of SAP in the young and middle-aged groups.
We found a greater rate of pseudocysts in our AP population, similar to [33], and we found that AAP could be a risk factor for pseudocyst development. In a prospective study, Cui et al. [34] observed that AAP may be a risk factor for pancreatic fluid collection, and some of those collections will transform into pseudocysts. Szako et al. [35] showed that, compared with biliary etiology, alcoholic etiology is linked only with old pseudocysts.
Despite the small number of cases with WON in our cohort, a majority of them were associated with AAP. This matter necessitates prospective studies or at least other retrospective studies on a larger population, as other research teams have not found any links between the two [36].
Although we documented a lower cost of hospitalization in our population than other studies have reported [37,38,39], all other studies have been conducted in countries with far greater GDP per capita. However, we obtained a similar relation between AAP and costs as two studies [37,38], indicating that AAP is cheaper to treat than biliary AP. Although we did not directly compare AAP with biliary AP, most likely the majority of cases from OAP group were biliary.
We were unable to find comparisons regarding the type of ward preferred for patients during hospitalization, as there are no studies in the literature that compare this variable in terms of treating AAP. We are working on expanding our registry into a multicentric one to determine if this association is maintained in other centers as well.
Considering that our country has a nearly 1:1 ratio between urban and rural populations and that access to healthcare systems is poor in rural areas, we sought to identify an association between patients’ area of residence and AAP. However, no association was found. Some studies on this topic, mainly originating in China, found contradictory results: Pang et al. [40] noted a higher diagnosis rate of all-cause AP in suburban areas, but Fan et al. [41] observed a lower-than-expected prevalence of AAP in suburban areas. A study from New Zealand [42] found no differences between urban and rural origins regarding all-cause AP. Some research [43] has investigated socioeconomic deprivation in patients with AP, but a correlation between this issue and living in a rural area may be difficult to make and should be made with caution.
Our association between tobacco use and AAP is somewhat contradictory to some of the available literature. Multiple studies refer to smoking tobacco products as a risk factor for developing AP [19,44,45,46,47], and some of them refer specifically to AAP, but they could not find a correlation between smoking tobacco and AAP [19,45,47], instead regarding smoking mainly as an independent risk factor for all-cause AP. Still, one interesting study [46] associated smoking tobacco, heavy drinking and alterations to the PRSS1 and PRSS2 genes, which have been linked to developing AAP. Further investigation into the association between smoking and drinking in developing AP is needed. A limitation of our analysis on this subject comes from the low available data on this topic.
No correlation between etiology and LoS was observed in our cohort. However, we obtained a lower median LoS in patients with AAP (7 days) than Easler et al. [48] did (20 days), a similar one with O’Farrell et al. [49] and a longer one than Nesvaderani et al. [27] (4 days). Although Balint et al. [32] also they found no association, another study [48] concluded that AAP cases have longer LoS than all other etiologies.
Our study has several limitations, most of them residing in its retrospective design. Namely, we had missing data in regard to tobacco usage, low count of WON observed, there were some missing data on behalf of their medical history, and it was impossible to estimate the cumulated dose of exposure to ethanol in order to assess if there are any dose-dependent effects. Another limitation of our study resides in the fact that all the patients studied are originating from a single center, we are now working to expand our registry to other centers. The lack of CAGE questionnaire in assessing alcoholism might also hinder the results of our study.

5. Conclusions

We found that AAP is closely linked to lower ICU admittance and lower costs of hospitalization. The typical sketch of a patient suffering from AAP is a middle-aged male patient less likely to suffer from in-hospital mortality, has RAP, including complications like pseudocysts, has been treated in a gastroenterological ward and is discharged against medical advice. We stress that large prospective studies are required in this particular field in order to validate our results.

Author Contributions

D.G., data curation, drafting, discussion and conclusions, and funding acquisition; A.V.E., literature review, drafting, introduction, corresponding author, and critical revision of the manuscript for important intellectual content; M.R.P., design of this study, literature review, data curation, statistical analysis and interpretation of data, drafting, material and methods and results; T.Ș.M., data curation, literature review, and drafting of the abstract; A.I.G. and A.S.O., data curation and literature review; C.M.P., data curation and critical revision of the manuscript for important intellectual content; L.N., conceptualization of this study and critical revision of the manuscript, including final approval. All authors have read and agreed to the published version of the manuscript.

Funding

Publication of this paper was supported by the University of Medicine and Pharmacy Carol Davila, through the institutional program Publish not Perish.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of University Emergency Hospital of Bucharest (IRB approval no. 11/2022, date 1 April 2022) for studies involving humans.

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

Data available upon reasonable request from the corresponding author. According to Romanian and EU laws publishing them can be considered a privacy data breach and as such we can not make them publicly available.

Acknowledgments

The authors would like to thank Dana Gabriela Corbu, Dalia Ioana Constantinescu, Irina Diaconu, Alexandru Olăreanu, Daniela Grigore, Damiana Ojog, Diana Nițu and Hossein Nayyerani for contributing to data curation in the BUC-API registry.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

AcronymsMeaning
APacute pancreatitis
AAPalcoholic acute pancreatitis
CDCCenter for Disease Control
GDPgross domestic product
ICUintensive care unit
IRBinstitutional review board
LoSlength of stay (days)
OAPall other known cause acute pancreatitis
RAPrecurrent acute pancreatitis
RONISO code of Romanian Leu (Romanian national currency)
SAPsevere acute pancreatitis
WONwalled-off necrosis

References

  1. Polishchuk, I.; Halperin, D.; Algedafy, A.; Delgado, J.-S.; Zamir, M.; Zamir, D. Epidemiology of Acute Pancreatitis in Southern Israel: A Retrospective Study. Isr. Med. Assoc. J. 2020, 22, 308–312. [Google Scholar]
  2. Belfrage, H.; Lankinen, E.; Kylänpää, L.; Louhimo, J. Acute Pancreatitis in Helsinki in 2016−2018: Incidence, Etiology and risk Factors—Analysis of 1378 acute pancreatitis episodes in a Finnish normal population. Scand. J. Gastroenterol. 2023, 58, 88–93. [Google Scholar] [CrossRef] [PubMed]
  3. Drinking Too Much Alcohol Can Harm Your Health. Learn the Facts|CDC. Available online: https://www.cdc.gov/alcohol/about-alcohol-use/index.html (accessed on 15 July 2023).
  4. Nieto, L.M.; Salazar, M.; Kinnucan, J.; Lukens, F.J.; Argueta, P.P. Incidence, Burden, and Predictors of Readmission for Acute Alcoholic Pancreatitis: A National Analysis over 11 Months. Dig. Dis. Sci. 2023, 68, 423–433. [Google Scholar] [CrossRef] [PubMed]
  5. Yasuda, H.; Horibe, M.; Sanui, M.; Sasaki, M.; Suzuki, N.; Sawano, H.; Goto, T.; Ikeura, T.; Takeda, T.; Oda, T.; et al. Etiology and mortality in severe acute pancreatitis: A multicenter study in Japan. Pancreatology 2020, 20, 307–317. [Google Scholar] [CrossRef] [PubMed]
  6. Li, C.; Jiang, M.; Pan, C.; Li, J.; Xu, L. The global, regional, and national burden of acute pancreatitis in 204 countries and territories, 1990–2019. BMC Gastroenterol. 2021, 21, 332. [Google Scholar] [CrossRef] [PubMed]
  7. Banks, P.A.; Bollen, T.L.; Dervenis, C.; Gooszen, H.G.; Johnson, C.D.; Sarr, M.G.; Tsiotos, G.G.; Vege, S.S.; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: Revision of the Atlanta classification and definitions by international consensus. Gut 2013, 62, 102–111. [Google Scholar] [CrossRef] [PubMed]
  8. Sleisenger and Fordtran’s Gastrointestinal and L-9780323636599|Elsevier Health. EU Elsevier Health. Available online: https://www.eu.elsevierhealth.com/sleisenger-and-fordtrans-gastrointestinal-and-liver-disease-review-and-assessment-9780323636599.html (accessed on 15 June 2023).
  9. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013, 13, e1–e15. [CrossRef] [PubMed]
  10. Ghiță, A.I.; Pahomeanu, M.R.; Negreanu, L. Epidemiological trends in acute pancreatitis: A retrospective cohort in a tertiary center over a seven year period. World J. Methodol. 2023, 13, 118–126. [Google Scholar] [CrossRef] [PubMed]
  11. Kim, Y.S.; Chang, J.H.; Kim, T.H.; Kim, C.W.; Kim, J.K.; Han, S.W. Prolonged hyperamylasemia in patients with acute pancreatitis is associated with recurrence of acute pancreatitis. Medicine 2020, 99, e18861. [Google Scholar] [CrossRef]
  12. Seppanen, H.; Puolakkainen, P. Classification, Severity Assessment, and Prevention of Recurrences in Acute Pancreatitis. Scand. J. Surg. 2020, 109, 53–58. [Google Scholar] [CrossRef]
  13. Cho, J.H.; Jeong, Y.H.; Kim, K.H.; Kim, T.N. Risk factors of recurrent pancreatitis after first acute pancreatitis attack: A retrospective cohort study. Scand. J. Gastroenterol. 2020, 55, 90–94. [Google Scholar] [CrossRef] [PubMed]
  14. Argueta, P.P.; Salazar, M.; Vohra, I.; Corral, J.E.; Lukens, F.J.; Vargo, J.J.; Chahal, P.; Simons-Linares, C.R. Thirty-Day Readmission among Patients with Alcoholic Acute Pancreatitis. Dig. Dis. Sci. 2021, 66, 4227–4236. [Google Scholar] [CrossRef] [PubMed]
  15. Goyal, H.; Guerreso, K.; Smith, B.; Harper, K.; Patel, S.; Patel, A.; Parikh, P. Severity and outcomes of acute alcoholic pancreatitis in cannabis users. Transl. Gastroenterol. Hepatol. 2017, 2, 60. [Google Scholar] [CrossRef] [PubMed]
  16. Kamal, A.; Akshintala, V.S.; Kamal, M.M.; El Zein, M.; Besharati, S.; Kumbhari, V.; Ngamruengphong, S.; Shin, E.J.; Singh, V.K.; Kalloo, A.N.; et al. Does Etiology of Pancreatitis Matter? Differences in Outcomes Among Patients with Post-Endoscopic Retrograde Cholangiopancreatography, Acute Biliary, and Alcoholic Pancreatitis. Pancreas 2019, 48, 574–578. [Google Scholar] [CrossRef] [PubMed]
  17. Lankisch, P.G.; Assmus, C.; Lehnick, D.; Maisonneuve, P.; Lowenfels, A.B. Acute Pancreatitis: Does Gender Matter? Dig. Dis. Sci. 2001, 46, 2470–2474. [Google Scholar] [CrossRef] [PubMed]
  18. Zhu, Y.; Pan, X.; Zeng, H.; He, W.; Xia, L.; Liu, P.; Zhu, Y.; Chen, Y.; Lv, N. A Study on the Etiology, Severity, and Mortality of 3260 Patients with Acute Pancreatitis According to the Revised Atlanta Classification in Jiangxi, China Over an 8-Year Period. Pancreas 2017, 46, 504–509. [Google Scholar] [CrossRef] [PubMed]
  19. Kume, K.; Masamune, A.; Ariga, H.; Shimosegawa, T. Alcohol Consumption and the Risk for Developing Pancreatitis: A Case-Control Study in Japan. Pancreas 2015, 44, 53–58. [Google Scholar] [CrossRef]
  20. Choi, N.G.; DiNitto, D.M. Heavy/binge drinking and depressive symptoms in older adults: Gender differences. Int. J. Geriatr. Psychiatry 2011, 26, 860–868. [Google Scholar] [CrossRef] [PubMed]
  21. Pope, S.; Smith, P.; Wayne, J.; Kelleher, K. Gender Differences in Rural Adolescent Drinking Patterns. J. Adolesc. Health 1994, 15, 359–365. [Google Scholar] [CrossRef]
  22. Witbrodt, J.; Mulia, N.; Zemore, S.E.; Kerr, W.C. Racial/Ethnic Disparities in Alcohol-Related Problems: Differences by Gender and Level of Heavy Drinking. Alcohol.-Clin. Exp. Res. 2014, 38, 1662–1670. [Google Scholar] [CrossRef]
  23. Samokhvalov, A.V.; Rehm, J.; Roerecke, M. Alcohol Consumption as a Risk Factor for Acute and Chronic Pancreatitis: A Systematic Review and a Series of Meta-analyses. EBioMedicine 2015, 2, 1996–2002. [Google Scholar] [CrossRef] [PubMed]
  24. Kim, J.E.; Hwang, J.-H.; Lee, S.H.; Cha, B.H.; Park, Y.S.; Kim, J.-W.; Jeong, S.-H.; Kim, N.; Lee, D.H. The clinical outcome of elderly patients with acute pancreatitis is not different in spite of the different etiologies and severity. Arch. Gerontol. Geriatr. 2012, 54, 256–260. [Google Scholar] [CrossRef] [PubMed]
  25. Matta, B.; Gougol, A.; Gao, X.; Reddy, N.; Talukdar, R.; Kochhar, R.; Goenka, M.K.; Gulla, A.; Gonzalez, J.A.; Singh, V.K.; et al. Worldwide Variations in Demographics, Management, and Outcomes of Acute Pancreatitis. Clin. Gastroenterol. Hepatol. 2020, 18, 1567–1575.e2. [Google Scholar] [CrossRef]
  26. Spanier, B.W.M.; Dijkgraaf, M.G.W.; Bruno, M.J. Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update. Best Pract. Res. Clin. Gastroenterol. 2008, 22, 45–63. [Google Scholar] [CrossRef] [PubMed]
  27. Nesvaderani, M.; Eslick, G.D.; Vagg, D.; Faraj, S.; Cox, M.R. Epidemiology, aetiology and outcomes of acute pancreatitis: A retrospective cohort study. Int. J. Surg. 2015, 23, 68–74. [Google Scholar] [CrossRef] [PubMed]
  28. Roberts, S.E.; Akbari, A.; Thorne, K.; Atkinson, M.; Evans, P.A. The incidence of acute pancreatitis: Impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment. Pharmacol. Ther. 2013, 38, 539–548. [Google Scholar] [CrossRef] [PubMed]
  29. Frey, C.F.; Zhou, H.; Harvey, D.J.; White, R.H. The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994–2001. Pancreas 2006, 33, 336–344. [Google Scholar] [CrossRef] [PubMed]
  30. Pu, W.; Luo, G.; Chen, T.; Jing, L.; Hu, Q.; Li, X.; Xia, H.; Deng, M.; Lü, M.; Chen, X. A 5-Year Retrospective Cohort Study: Epidemiology, Etiology, Severity, and Outcomes of Acute Pancreatitis. Pancreas 2020, 49, 1161–1167. [Google Scholar] [CrossRef] [PubMed]
  31. Garcia, S.C.; Toolis, M.; Ubels, M.; Mollah, T.; Paul, E.; Pandey, A.; Thia, B.; Wong, T.; Tiruvoipati, R. Comparison of clinical characteristics and outcomes between alcohol-induced and gallstone-induced acute pancreatitis: An Australian retrospective observational study. SAGE Open Med. 2021, 9, 205031212110308. [Google Scholar] [CrossRef]
  32. Bálint, E.R.; Fűr, G.; Kiss, L.; Németh, D.I.; Soós, A.; Hegyi, P.; Szakács, Z.; Tinusz, B.; Varjú, P.; Vincze, Á.; et al. Assessment of the course of acute pancreatitis in the light of aetiology: A systematic review and meta-analysis. Sci. Rep. 2020, 10, 17936. [Google Scholar] [CrossRef]
  33. Kim, K.O.; Kim, T.N. Acute Pancreatic Pseudocyst Incidence, Risk Factors, and Clinical Outcomes. Pancreas 2012, 41, 577–581. [Google Scholar] [CrossRef] [PubMed]
  34. Cui, M.L.; Kim, K.H.; Kim, H.G.; Han, J.; Kim, H.; Cho, K.B.; Jung, M.K.; Cho, C.M.; Kim, T.N. Incidence, risk factors and clinical course of pancreatic fluid collections in acute pancreatitis. Dig. Dis. Sci. 2014, 59, 1055–1062. [Google Scholar] [CrossRef] [PubMed]
  35. Szako, L.; Gede, N.; Váradi, A.; Tinusz, B.; Vörhendi, N.; Mosztbacher, D.; Vincze, Á.; Takács, T.; Czakó, L.; Izbéki, F.; et al. Early occurrence of pseudocysts in acute pancreatitis—A multicenter international cohort analysis of 2275 cases. Pancreatology 2021, 21, 1161–1172. [Google Scholar] [CrossRef] [PubMed]
  36. Verdonk, R.C.; Sternby, H.; Dimova, A.; Ignatavicius, P.; Koiva, P.; Penttila, A.K.; Ilzarbe, L.; Regner, S.; Rosendahl, J.; Bollen, T.L. Presence, extent and location of pancreatic necrosis are independent of aetiology in acute pancreatitis. Eur. J. Gastroenterol. Hepatol. 2018, 30, 342–345. [Google Scholar] [CrossRef] [PubMed]
  37. Andersson, B.; Appelgren, B.; Sjödin, V.; Ansari, D.; Nilsson, J.; Persson, U.; Tingstedt, B.; Andersson, R. Acute pancreatitis—Costs for healthcare and loss of production. Scand. J. Gastroenterol. 2013, 48, 1459–1465. [Google Scholar] [CrossRef] [PubMed]
  38. Sharma, S.; Nehme, C.; Aziz, M.; Weissman, S.; Khan, A.; Acharya, A.; Vohra, I.; Ghazaleh, S.; Nawras, A.; Adler, D.G. Acute biliary pancreatitis has better outcomes but increased resource utilization compared to acute alcohol-induced pancreatitis: Insights from a nationwide study. Ann. Gastroenterol. 2021, 34, 253–261. [Google Scholar] [CrossRef] [PubMed]
  39. Peery, A.F.; Crockett, S.D.; Murphy, C.C.; Jensen, E.T.; Kim, H.P.; Egberg, M.D.; Lund, J.L.; Moon, A.M.; Pate, V.; Barnes, E.L.; et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021. Gastroenterology 2022, 162, 621–644. [Google Scholar] [CrossRef]
  40. Pang, Y.; Kartsonaki, C.; Turnbull, I.; Guo, Y.; Yang, L.; Bian, Z.; Chen, Y.; Millwood, I.Y.; Bragg, F.; Gong, W.; et al. Metabolic and lifestyle risk factors for acute pancreatitis in Chinese adults: A prospective cohort study of 0.5 million people. PLOS Med. 2018, 15, e1002618. [Google Scholar] [CrossRef]
  41. Fan, J.; Ding, L.; Lu, Y.; Zheng, J.; Zeng, Y.; Huang, C. Epidemiology and Etiology of Acute Pancreatitis in Urban and Suburban Areas in Shanghai: A Retrospective Study. Gastroenterol. Res. Pract. 2018, 2018, 1420590. [Google Scholar] [CrossRef]
  42. Birrell, L.; McGuinness, M.; Elliott, B.; Harmston, C. Effect of rurality and ethnicity in severity and outcomes in patients with acute pancreatitis. ANZ J. Surg. 2021, 91, 1558–1562. [Google Scholar] [CrossRef]
  43. Ellis, M.P.; French, J.J.; Charnley, R.M. Acute pancreatitis and the influence of socioeconomic deprivation. Br. J. Surg. 2008, 96, 74–80. [Google Scholar] [CrossRef]
  44. Yadav, D.; Hawes, R.H.; Brand, R.E.; Anderson, M.A.; Money, M.E.; Banks, P.A.; Bishop, M.D.; Baillie, J.; Sherman, S.; DiSario, J.; et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch. Intern. Med. 2009, 169, 1035–1045. [Google Scholar] [CrossRef] [PubMed]
  45. Lindkvist, B.; Appelros, S.; Manjer, J.; Berglund, G.; Borgström, A. A Prospective Cohort Study of Smoking in Acute Pancreatitis. Pancreatology 2008, 8, 63–70. [Google Scholar] [CrossRef] [PubMed]
  46. Polonikov, A.V.; Samgina, T.A.; Nazarenko, P.M.; Bushueva, O.Y.; Ivanov, V.P. Alcohol Consumption and Cigarette Smoking are Important Modifiers of the Association Between Acute Pancreatitis and the PRSS1-PRSS2 Locus in Men. Pancreas 2017, 46, 230–236. [Google Scholar] [CrossRef]
  47. Tolstrup, J.S.; Kristiansen, L.; Becker, U.; Grønbæk, M. Smoking and Risk of Acute and Chronic Pancreatitis Among Women and Men: A Population-Based Cohort Study. Arch. Intern. Med. 2009, 169, 603–609. [Google Scholar] [CrossRef] [PubMed]
  48. Easler, J.J.; De-Madaria, E.; Nawaz, H.; Moya-Hoyo, N.; Koutroumpakis, E.; Rey-Riveiro, M.; Singh, V.P.; Acevedo-Piedra, N.G.; Whitcomb, D.C.; Yadav, D.; et al. Patients with Sentinel Acute Pancreatitis of Alcoholic Etiology Are at Risk for Organ Failure and Pancreatic Necrosis: A Dual-Center Experience. Pancreas 2016, 45, 997–1002. [Google Scholar] [CrossRef]
  49. O’Farrell, A.; Allwright, S.; Toomey, D.; Bedford, D.; Conlon, K. Hospital admission for acute pancreatitis in the Irish population, 1997 2004: Could the increase be due to an increase in alcohol-related pancreatitis? J. Public Health 2007, 29, 398–404. [Google Scholar] [CrossRef]
Figure 1. Recurrence related to etiology.
Figure 1. Recurrence related to etiology.
Biomedicines 12 01299 g001
Figure 2. Gender distribution across groups.
Figure 2. Gender distribution across groups.
Biomedicines 12 01299 g002
Figure 3. Age distribution in the two patient groups.
Figure 3. Age distribution in the two patient groups.
Biomedicines 12 01299 g003
Figure 4. ICU admittance across groups.
Figure 4. ICU admittance across groups.
Biomedicines 12 01299 g004
Figure 5. Distribution of morphology across groups.
Figure 5. Distribution of morphology across groups.
Biomedicines 12 01299 g005
Table 1. Registry population characteristics.
Table 1. Registry population characteristics.
AP Patients (n = 1618)
Recurrence
Acute pancreatitis (first known attack)1388 (85.8%)
Recurrent AP230 (14.2%)
Age (years)
Median59.0 (IQR = 26.0)
Mean57.7 (SD = 17.1)
Length of stay (LoS)
Median7.0 (IQR = 6.0)
Mean8.8 (SD = 7.8)
Daily cost of hospitalization (EUR)
Median177.2 (IQR = 93.2)
Mean419.4 (SD = 3475.8)
Etiology
Alcoholic503 (31.1%)
Idiopathic253 (15.6%)
All other known causes 862 (53.3%)
Sex
Male918 (56.7%)
Female700 (43.3%)
Severity
Mild821 (50.7%)
Moderate to severe590 (36.5%)
Severe207 (12.8%)
Morphology
Interstitial626 (38.7%)
Normal pancreas245 (15.1%)
APFC115 (7.1%)
ANC50 (3.1%)
Pseudocyst74 (4.6%)
WON4 (0.2%)
No data504 (31.1%)
Outcome
Healed/ameliorated1329 (82.1%)
Discharged at-will96 (5.9%)
Deceased108 (6.7%)
Transferred74 (4.6%)
Stationary11 (0.7%)
ICU admittance
No1449 (89.6%)
Yes169 (10.4%)
Tobacco use
Active250 (15.5%)
Former (>4 weeks)73 (4.5%)
Never32 (2.0%)
No data1263 (78.1%)
Ward of origin
Gastroenterology788 (48.7%)
Surgery830 (51.3%)
Patient area of origin
Urban1159 (71.6%)
Rural445 (27.5%)
Foreign6 (0.4%)
No data8 (0.5%)
Table 2. Clinical and demographic characteristics of patients with AAP and other known etiologies of AP.
Table 2. Clinical and demographic characteristics of patients with AAP and other known etiologies of AP.
Alcoholic Etiology
(n = 503)
Other Etiologies
(n = 1115)
p-Value
Recurrence
AP (first known attack)364 (72.4%)1024 (91.8%)p < 0.01
Recurrent AP139 (27.6%)91 (8.2%)
Sex
Male447 (88.9%)471 (42.2%)p < 0.01
Female56 (11.2%)644 (57.8%)
Outcome at discharge
Healed/Ameliorated421 (83.7%)908 (81.4%)p < 0.01
Stationary3 (0.5%)8 (0.8%)
Transferred9 (1.8%)65 (5.8%)
Discharge at will48 (9.6%)48 (4.3%)
Deceased22 (4.4%)86 (7.7%)
Type of ward
Gastroenterological415 (82.5%)373 (33.5%)p < 0.01
Surgical88 (17.5%)742 (66.5%)
ICU admittance
Yes29 (5.8%)140 (12.6%)p < 0.01
No474 (94.2%)975 (87.4%)
Severity
Mild265 (52.7%)556 (49.9%)p = 0.28
Moderate to severe183 (36.4%)407 (36.5%)
Severe55 (10.9%)152 (13.6%)
Morphology
Interstitial218 (43.3%)408 (36.6%)
APFC49 (9.7%)66 (5.9%)
Pseudocyst39 (7.8%)35 (3.2%)p < 0.01
ANC12 (2.4%)38 (3.4%)
WON3 (0.6%)1 (0.1%)
Normal pancreas61 (12.1%)184 (16.5%)
No data121 (24.1%)383 (34.3%)
Urban or rural residency
Urban347 (69.0%)812 (72.8%)p = 0.23
Rural147 (29.2%)298 (26.7%)
No data9 (1.8%)5 (0.5%)
Tobacco usage
Active182 (36.2%)68 (6.1%)p < 0.01
Former43 (8.5%)30 (2.7%)
Never10 (2.0%)22 (2.0%)
No data268 (53.3%)995 (89.2%)
Patient age (years)
Median51.0 (IQR = 18.0)63.0 (IQR = 27.0)p < 0.01
Mean52.0 (SD = 13.0)60.3 (SD = 18.1)
Length of stay (days)
Median7.0 (IQR = 5.0)7.0 (IQR = 6.0)p = 0.99
Mean8.7 (SD = 8.6)8.8 (SD = 7.4)
Daily cost of hospitalization (EUR)
Median154.7 (IQR = 62.0)204.4 (IQR = 83.3)p < 0.01
Mean311.1 (SD = 2878.9)552.4 (SD = 4029.1)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gűnșahin, D.; Edu, A.V.; Pahomeanu, M.R.; Mitu, T.Ș.; Ghiță, A.I.; Odorog, A.S.; Preda, C.M.; Negreanu, L. Alcoholic Acute Pancreatitis, a Retrospective Study about Clinical Risk Factors and Outcomes—A Seven-Year Experience of a Large Tertiary Center. Biomedicines 2024, 12, 1299. https://doi.org/10.3390/biomedicines12061299

AMA Style

Gűnșahin D, Edu AV, Pahomeanu MR, Mitu TȘ, Ghiță AI, Odorog AS, Preda CM, Negreanu L. Alcoholic Acute Pancreatitis, a Retrospective Study about Clinical Risk Factors and Outcomes—A Seven-Year Experience of a Large Tertiary Center. Biomedicines. 2024; 12(6):1299. https://doi.org/10.3390/biomedicines12061299

Chicago/Turabian Style

Gűnșahin, Deniz, Andrei Vicențiu Edu, Mihai Radu Pahomeanu, Tudor Ștefan Mitu, Andreea Irina Ghiță, Anamaria Simona Odorog, Carmen Monica Preda, and Lucian Negreanu. 2024. "Alcoholic Acute Pancreatitis, a Retrospective Study about Clinical Risk Factors and Outcomes—A Seven-Year Experience of a Large Tertiary Center" Biomedicines 12, no. 6: 1299. https://doi.org/10.3390/biomedicines12061299

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop